合作单位_Partnerships_Research and Development_Tonghua Dongbao

Corporate Email

中

中

Contact:

4008465777

×

Research and Development

YPsomed AG

YPsomed and Tonghua Dongbao have extensive cooperation in pen needles, and reusable/disposable pens. Further cooperation is expected in insulin pumps and automatic injectors.
Shanghai Applied Protein Technology Co., Ltd.
Hangzhou Tigermed Technology Co., Ltd.
Shanghai MedKey Med-Tech Development Co., Ltd.

Tonghua Dongbao and Medkey (Subsidiary of Wuxi Apptech) has formed a long-term partnership and always maintain mutual trust and active cooperation in clinical R&D.
Parexel APEX (Shanghai) Co., Ltd.
GCP ClinPlus (Beijing) Co., Ltd.
Guangzhou KingMed Diagnostics Group Co., Ltd.
Sweden Rechon Life Science AB

Rechon Life Science assists Tonghua Dongbao in market exploration and product registration in Europe and provides services to ensure GMP is in compliance with the EMEA and the U.S. FDA.
SA Adocia

Adocia has authorized Tonghua Dongbao to develop, register, produce, and sell two insulin products (ultra-rapid insulin) in China and Southeast Asia.
Shanghai Xihua Scientific Co., Ltd.
Kexing Biopharm

Tonghua Dongbao will give Kexing Biopharm exclusive rights to sell its liraglutide injections in 17 emerging markets overseas.
Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd

usdt官网入口